Dier Mardi, EVP and CFO of Madrigal Pharmaceuticals ($MDGL), sold about $3.8 million in company shares across 28 open market transactions over the past year. His most recent sale occurred on March 6, 2026. These sales rank 2,331st among 11,678 insiders in our database, below the average of $8.6 million per seller and 6.4 transactions. Dier Mardi made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 80 | $427.85 | 13,286.0000 | 22,939,969 | 0.60% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 40 | $437.65 | 12,490.0000 | 22,939,969 | 0.32% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 80 | $436.69 | 12,530.0000 | 22,939,969 | 0.63% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 80 | $435.32 | 12,610.0000 | 22,939,969 | 0.63% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 160 | $429.00 | 13,126.0000 | 22,939,969 | 1.20% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 160 | $434.20 | 12,690.0000 | 22,939,969 | 1.25% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 116 | $432.56 | 12,850.0000 | 22,939,969 | 0.89% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 120 | $430.90 | 12,966.0000 | 22,939,969 | 0.92% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 40 | $429.58 | 13,086.0000 | 22,939,969 | 0.30% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 420 | $426.86 | 13,366.0000 | 22,939,969 | 3.05% | 0.00% |
| March 4, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | A | Stock Option (Right to Buy) | 6519 | $0.00 | 6,519.0000 | 22,939,969 | 9999.99% | 0.03% |
| March 4, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | A | Common Stock | 5215 | $0.00 | 14,472.0000 | 22,939,969 | 56.34% | 0.02% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 646 | $431.94 | 13,826.0000 | 22,939,969 | 4.46% | 0.00% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 40 | $425.08 | 13,786.0000 | 22,939,969 | 0.29% | 0.00% |
| March 2, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 1183 | $427.21 | 9,257.0000 | 22,939,969 | 11.33% | 0.01% |
| Jan. 2, 2026 | Oric Pharmaceuticals, Inc. | $ORIC | Dier Mardi | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 98,953,331 | 9999.99% | 0.04% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | M | Stock Option (Right to Buy) | 4173 | $0.00 | 9,180.0000 | 22,711,420 | 31.25% | 0.02% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 160 | $589.65 | 10,754.0000 | 22,711,420 | 1.47% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | M | Common Stock | 4173 | $251.63 | 14,613.0000 | 22,711,420 | 39.97% | 0.02% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 320 | $570.39 | 14,293.0000 | 22,711,420 | 2.19% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 410 | $571.99 | 13,883.0000 | 22,711,420 | 2.87% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 354 | $573.02 | 13,529.0000 | 22,711,420 | 2.55% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 717 | $574.00 | 12,812.0000 | 22,711,420 | 5.30% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 120 | $574.95 | 12,692.0000 | 22,711,420 | 0.94% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 240 | $576.15 | 12,452.0000 | 22,711,420 | 1.89% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 320 | $577.81 | 12,132.0000 | 22,711,420 | 2.57% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 258 | $578.83 | 11,874.0000 | 22,711,420 | 2.13% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 480 | $579.85 | 11,394.0000 | 22,711,420 | 4.04% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 240 | $585.44 | 11,154.0000 | 22,711,420 | 2.11% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 240 | $587.85 | 10,914.0000 | 22,711,420 | 2.15% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 160 | $590.37 | 10,594.0000 | 22,711,420 | 1.49% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 74 | $595.20 | 10,520.0000 | 22,711,420 | 0.70% | 0.00% |
| Dec. 2, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | EVP and CFO | S | Common Stock | 80 | $596.19 | 10,440.0000 | 22,711,420 | 0.76% | 0.00% |
| June 12, 2025 | Prelude Therapeutics Inc | $PRLD | Dier Mardi | Not found | A | Director Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 75,805,840 | 9999.99% | 0.05% |
| March 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | SVP and CFO | S | Common Stock | 258 | $323.04 | 10,440.0000 | 22,080,246 | 2.41% | 0.00% |
| March 5, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | SVP and CFO | A | Common Stock | 3784 | $0.00 | 10,698.0000 | 22,080,246 | 54.73% | 0.02% |
| March 5, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | SVP and CFO | A | Stock Option (Right to Buy) | 6374 | $0.00 | 6,374.0000 | 22,080,246 | 9999.99% | 0.03% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | SVP and CFO | S | Common Stock | 1187 | $325.89 | 7,688.0000 | 22,080,246 | 13.37% | 0.01% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Dier Mardi | SVP and CFO | S | Common Stock | 774 | $323.54 | 6,914.0000 | 22,080,246 | 10.07% | 0.00% |
| Jan. 2, 2025 | Oric Pharmaceuticals, Inc. | $ORIC | Dier Mardi | Not found | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 69,727,940 | 9999.99% | 0.05% |
| June 14, 2024 | Prelude Therapeutics Inc | $PRLD | Dier Mardi | Not found | A | Director Stock Option (Right to Buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 12, 2024 | Oric Pharmaceuticals, Inc. | $ORIC | Dier Mardi | Not found | A | Stock Option (right to buy) | 25600 | $0.00 | 25,600.0000 | 51,450,848 | 9999.99% | 0.05% |